S&P 500

7,580.07

-140.32

-1.82%

Dow 30

51,770.31

-572.25

-1.09%

Nasdaq

25,437.00

-747.73

-2.86%

Russell 2000

2,811.84

-47.37

-1.66%

10-Yr Bond

4.9290

-0.0600

-1.20%

VIX

19.42

+2.22

+12.91%

Gold

3,898.90

-132.50

-3.29%

Bitcoin USD

77,859.99

+494.36

+0.64%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

HKSE - Delayed Quote HKD

China Everbright Limited (0165.HK)

4.935 -0.225 (-4.36%)

At close: October 30 at 4:08:06 PM GMT+8

Loading Chart for 0165.HK

Chart Range Bar

Interval:

In partnership with ChartIQ

Did Court Appeals Just Shift China Everbright's (SEHK:165) Investment Narrative?

China Everbright Ltd's Dividend Analysis

Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms

Is China Everbright (SEHK:165) Still Worth A Premium After Its 70% To 80% Profit Warning?

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets closed

China Everbright Limited (0165.HK)

Recent News

Did Court Appeals Just Shift China Everbright's (SEHK:165) Investment Narrative?

China Everbright Ltd's Dividend Analysis

Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms

Is China Everbright (SEHK:165) Still Worth A Premium After Its 70% To 80% Profit Warning?

Related Tickers